Literature DB >> 12791314

The role of interleukin-10 in systemic lupus erythematosus.

Luis Llorente1, Yvonne Richaud-Patin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12791314     DOI： 10.1016/s0896-8411(03)00043-x

Source DB:  PubMed          Journal:  J Autoimmun        ISSN： 0896-8411            Impact factor:   7.094


× No keyword cloud information.
  12 in total

1.  Altered IL-10 and TNF-α production in peripheral blood mononuclear cells of systemic lupus erythematosus patients after Toll-like receptor 2, 4, or 9 activation.

Authors:  Jeng-Ting Tsao; Song-Chou Hsieh; Bor-Luen Chiang; Chia-Li Yu; Shih-Chang Lin
Journal:  Clin Exp Med       Date:  2011-11-05       Impact factor: 3.984

2.  B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice.

Authors:  Patrizia Scapini; Chrystelle Lamagna; Yongmei Hu; Karim Lee; Qizhi Tang; Anthony L DeFranco; Clifford A Lowell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-12       Impact factor: 11.205

Review 3.  Efficacy and cytokine modulating effects of tacrolimus in systemic lupus erythematosus: a review.

Authors:  Kam Hon Yoon
Journal:  J Biomed Biotechnol       Date:  2010-06-28

4.  Agrin signalling contributes to cell activation and is overexpressed in T lymphocytes from lupus patients.

Authors:  Elizabeth C Jury; Jillian Eldridge; David A Isenberg; Panagiotis S Kabouridis
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

5.  Successful treatment of class V+IV lupus nephritis with multitarget therapy.

Authors:  Hao Bao; Zhi-Hong Liu; Hong-Lang Xie; Wei-Xin Hu; Hai-Tao Zhang; Lei-Shi Li
Journal:  J Am Soc Nephrol       Date:  2008-07-02       Impact factor: 10.121

Review 6.  Dendritic cells and the immunopathogenesis of systemic lupus erythematosus.

Authors:  Seetha Monrad; Mariana J Kaplan
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

7.  Mechanism and regulatory function of CpG signaling via scavenger receptor B1 in primary B cells.

Authors:  Peimin Zhu; Xiaohong Liu; Laura S Treml; Michael P Cancro; Bruce D Freedman
Journal:  J Biol Chem       Date:  2009-06-19       Impact factor: 5.157

8.  SM934 treated lupus-prone NZB × NZW F1 mice by enhancing macrophage interleukin-10 production and suppressing pathogenic T cell development.

Authors:  Li-Fei Hou; Shi-Jun He; Xin Li; Chun-Ping Wan; Yang Yang; Xiao-Hui Zhang; Pei-Lan He; Yu Zhou; Feng-Hua Zhu; Yi-Fu Yang; Ying Li; Wei Tang; Jian-Ping Zuo
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

Review 9.  Immunological aspects in chronic lymphocytic leukemia (CLL) development.

Authors:  Ricardo García-Muñoz; Verónica Roldan Galiacho; Luis Llorente
Journal:  Ann Hematol       Date:  2012-04-12       Impact factor: 3.673

10.  Normally occurring NKG2D+CD4+ T cells are immunosuppressive and inversely correlated with disease activity in juvenile-onset lupus.

Authors:  Zhenpeng Dai; Cameron J Turtle; Garrett C Booth; Stanley R Riddell; Theodore A Gooley; Anne M Stevens; Thomas Spies; Veronika Groh
Journal:  J Exp Med       Date:  2009-03-16       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.